Correction: Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings
0
by Lisa A. de Jong, Jessie Groeneveld, Jelena Stevanovic, Harrie Rila, Robert G. Tieleman, Menno V. Huisman, Maarten J. Postma, Marinus van Hulst